Amends TCA Title 8; Title 56; Title 63; Title 68 and Title 71.

Tennessee HB1956 expands the existing prohibition on the use of step therapy protocols for health benefit plans by removing the limitation to stage 4 advanced metastatic cancer or metastatic blood cancer, applying it to any cancer diagnosis. This change affects enrollees diagnosed with cancer who require coverage for approved prescription drugs. Key provisions include the broader applicability of the prohibition against step therapy for all cancer types, ensuring that patients receive timely access to necessary medications without prior authorization hurdles.